Bio-Rad Laboratories (BIO) Operating Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Operating Margin of 5.76% for Q1 2026, up 171.0% year-over-year from 2.13% in Q1 2025, and up 133.58% quarter-over-quarter from 17.15% in Q4 2025.
Bio-Rad Laboratories (BIO) Operating Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Operating Margin data on file, last reported at 5.76% in Q1 2026.
- Operating Margin for Q1 2026 came in at 5.76%, up 171.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.22% (down 754.0% YoY), and the FY2025 annual result was 1.83%, down 865.0% from the prior year.
- Operating Margin improved to 5.76% in Q1 2026 per BIO's latest filing, from 17.15% in the prior quarter.
- Over five years, Operating Margin peaked at 20.91% in Q1 2022 and troughed at 17.15% in Q4 2025.
- A 5-year average of 10.35% and a median of 11.83% in 2025 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2025: Operating Margin jumped 703 bps in 2022, then plunged 2589 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 16.25% in 2022, then declined by 14 bps to 13.99% in 2023, then tumbled by 38 bps to 8.73% in 2024, then tumbled by 296 bps to 17.15% in 2025, then jumped by 134 bps to 5.76% in 2026.
- Business Quant data shows BIO's Operating Margin at 5.76% in Q1 2026, 17.15% in Q4 2025, and 10.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | Bio-Rad Laboratories | 7.70 Bn | 6.13 Bn | 309.40 Mn | 5.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.76% |
| Dec 31, 2025 | -17.15% |
| Sep 30, 2025 | 10.00% |
| Jun 30, 2025 | 11.83% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 8.73% |
| Sep 30, 2024 | 9.93% |
| Jun 30, 2024 | 15.90% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | 13.99% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | 13.16% |
| Mar 31, 2023 | 9.15% |
| Dec 31, 2022 | 16.25% |
| Sep 30, 2022 | 13.90% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | 20.91% |
| Dec 31, 2021 | 16.09% |
| Sep 30, 2021 | 20.99% |
| Jun 30, 2021 | 17.43% |